Literature DB >> 18377548

Lessons learned from the pediatric heart transplant study.

Daphne T Hsu1, David C Naftel, Steven A Webber, William R Morrow, Charles E Canter, Richard E Chinnock, Mary Lynne Clark, James K Kirklin.   

Abstract

The Pediatric Heart Transplant Study (PHTS) group was founded in 1991 as a voluntary, collaborative effort dedicated to the advancement of the science and treatment of children following listing for heart transplantation. Since 1993, the PHTS has collected data in an international, prospective, event-driven database that examines risk factors for outcome events following listing for transplantation. The events include transplantation, death, rejection, infection, malignancy, graft vasculopathy, and retransplantation. Over its 12 years of existence, the PHTS has made major contributions to the field of pediatric heart transplantation, especially in the areas of outcome analysis and risk factor assessment for death and other major morbidities after listing and after transplantation. The new challenges facing the PHTS include how to implement the practice of evidence-based medicine in the field of pediatric heart transplantation and how to support ongoing data collection and analysis to provide long-term outcomes as the PHTS subjects enter their second decade after transplantation.

Entities:  

Mesh:

Year:  2006        PMID: 18377548     DOI: 10.1111/j.1747-0803.2006.00011.x

Source DB:  PubMed          Journal:  Congenit Heart Dis        ISSN: 1747-079X            Impact factor:   2.007


  4 in total

1.  The impact of heart failure severity at time of listing for cardiac transplantation on survival in pediatric cardiomyopathy.

Authors:  Ranae L Larsen; Charles E Canter; David C Naftel; Margaret Tressler; David N Rosenthal; Elizabeth D Blume; William T Mahle; Delphine Yung; William R Morrow; E John Orav; James D Wilkinson; Jeffrey A Towbin; Stephen E Lipshultz
Journal:  J Heart Lung Transplant       Date:  2011-03-17       Impact factor: 10.247

2.  Multi-institutional Study of Outcomes After Pediatric Heart Transplantation: Candidate Gene Polymorphism Analysis of ABCC2.

Authors:  Gilbert J Burckart; William D Figg; Maria M Brooks; Dionna J Green; Sarah M Troutman; Robert Ferrell; Richard Chinnock; Charles Canter; Linda Addonizio; Daniel Bernstein; James K Kirklin; David Naftel; Douglas K Price; Tristan M Sissung; Diana M Girnita; Adriana Zeevi; Steven A Webber
Journal:  J Pediatr Pharmacol Ther       Date:  2014-01

3.  Renal function and genetic polymorphisms in pediatric heart transplant recipients.

Authors:  Brian Feingold; Maria M Brooks; Adriana Zeevi; Erin L Ohmann; Gilbert J Burckart; Robert E Ferrell; Richard Chinnock; Charles Canter; Linda Addonizio; Daniel Bernstein; James K Kirklin; David C Naftel; Steven A Webber
Journal:  J Heart Lung Transplant       Date:  2012-07-11       Impact factor: 10.247

4.  Association Between Thiopurine S-Methyltransferase (TPMT) Genetic Variants and Infection in Pediatric Heart Transplant Recipients Treated With Azathioprine: A Multi-Institutional Analysis.

Authors:  Dionna J Green; Son Q Duong; Gilbert J Burckart; Tristan Sissung; Douglas K Price; William D Figg; Maria M Brooks; Richard Chinnock; Charles Canter; Linda Addonizio; Daniel Bernstein; David C Naftel; Adriana Zeevi; James K Kirklin; Steven A Webber; Brian Feingold
Journal:  J Pediatr Pharmacol Ther       Date:  2018 Mar-Apr
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.